top of page

Intensic 40 mg Injection

SKU Neon Laboratories Ltd
Original price

$5.01

Sale price

$3.91

Intensic 40 mg injection is a potent topoisomerase inhibitor specifically designed for the management of advanced colorectal cancer. This injectable medication may be effectively combined with 5-fluorouracil and folinic acid for patients who have not previously undergone chemotherapy for their advanced disease. Intensic is particularly valuable in the first-line treatment of metastatic carcinoma of the colon or rectum, either used alone or alongside other therapeutic agents. As with any cancer treatment, patients should be aware of potential side effects, which may include gastrointestinal issues and bone marrow suppression. It is crucial to monitor blood counts regularly during therapy to mitigate these risks. Before starting treatment with Intensic, patients should discuss their complete medical history with their healthcare provider to ensure safe usage. With its targeted action, Intensic 40 mg injection plays a significant role in improving outcomes for those battling advanced stages of colorectal cancer. Always consult your healthcare professional for personalized advice and recommendations regarding treatment options.

Quantity

Active Pharmaceutical Ingredient

Irinotecan 40 mg

Uses

• Intensic 40 mg injection is primarily used in the treatment of certain types of cancer, particularly colorectal cancer. It works by interfering with the cancer cell's ability to grow and divide. This medication is often part of a combination chemotherapy regimen, enhancing the overall effectiveness of the treatment plan. Patients typically receive Intensic 40 mg injection in a hospital or clinical setting under the supervision of healthcare professionals.
• The administration of Intensic 40 mg injection is tailored to the specific type and stage of cancer being treated. Healthcare providers evaluate individual patient factors to create a personalized treatment plan. This approach ensures that the therapy is both effective and appropriate for the patient’s condition. By using Intensic 40 mg injection, healthcare teams aim to improve patient outcomes and manage cancer progression.
• Intensic 40 mg injection may also be utilized in cases where other cancer treatments have not been successful. Its role in combination therapies helps to target cancer cells more effectively. This can lead to improved responses in patients who may not have had favorable outcomes with other medications. The use of Intensic 40 mg injection reflects a strategic approach to cancer management, focusing on maximizing therapeutic benefits.
• In addition to colorectal cancer, Intensic 40 mg injection is sometimes indicated for other malignancies as determined by oncologists. Its effectiveness in disrupting the life cycle of cancer cells makes it a valuable tool in oncology. The treatment plan involving Intensic 40 mg injection is carefully monitored to assess its impact on the patient’s health. Oncologists use this medication to help control symptoms and improve the quality of life for patients undergoing cancer treatment.

Benefits

Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Intensic 40 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

Side Effects

Like all medications, Anti-cancer Injection Intensic can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Most Common Side Effects

• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain

Common Side Effects

• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count

How To Use

Irinotecan Injection 40 mg is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Intensic 40 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Intensic 40 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Intensic 40 mg and report any unusual symptoms or changes in kidney function to their doctor. Intensic 40 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggest that Intensic 40 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of Intensic 40 mg Vial therapy.
• Liver: Irinotecan Injection 40 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Anti-cancer Injection Intensic and report any unusual symptoms or changes in liver function to their doctor. The dose of Intensic 40 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Irinotecan Injection 40 mg has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Intensic 40 mg, Intensic 40 mg Injection should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Intensic Injection until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Intensic 40 mg Injection.
• Driving: Intensic 40 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances, which may occur within 24 hours following the administration of Intensic Injection, and advised not to drive or operate machinery if these symptoms occur.

bottom of page